Michael Charlton

NPI: 1821064692
Total Payments
$360,944
2024 Payments
$44,827
Companies
27
Transactions
220
Medicare Patients
419
Medicare Billing
$62,568

Payment Breakdown by Category

Consulting$319,516 (88.5%)
Travel$19,834 (5.5%)
Other$16,190 (4.5%)
Food & Beverage$5,404 (1.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $319,516 71 88.5%
Travel and Lodging $19,834 53 5.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,250 3 3.4%
Food and Beverage $5,404 90 1.5%
Honoraria $3,940 3 1.1%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $151,767 109 $0 (2023)
Novo Nordisk Inc $69,703 27 $0 (2024)
Madrigal Pharmaceuticals $26,106 2 $0 (2024)
PFIZER INC. $20,844 11 $0 (2024)
Intercept Pharmaceuticals, Inc. $14,108 8 $0 (2020)
Merck Sharp & Dohme LLC $13,173 11 $0 (2022)
Bard Peripheral Vascular, Inc. $13,163 7 $0 (2024)
GlaxoSmithKline, LLC. $11,289 4 $0 (2024)
E.R. Squibb & Sons, L.L.C. $8,533 3 $0 (2021)
Shire North American Group Inc $8,170 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $44,827 12 Madrigal Pharmaceuticals ($26,106)
2023 $39,887 20 Novo Nordisk Inc ($20,326)
2022 $52,696 24 Novo Nordisk Inc ($28,529)
2021 $49,861 15 Novo Nordisk Inc ($14,985)
2020 $24,930 6 Intercept Pharmaceuticals, Inc. ($7,800)
2019 $58,903 47 Gilead Sciences, Inc. ($48,891)
2018 $34,902 38 Gilead Sciences, Inc. ($26,086)
2017 $54,937 58 Gilead Sciences Inc ($44,851)

All Payment Transactions

220 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
09/18/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Consulting Fee Cash or cash equivalent $25,530.00 General
Category: LIVER DISEASE
09/12/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Consulting Fee Cash or cash equivalent $575.51 General
Category: LIVER DISEASE
09/06/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $4,800.00 General
09/06/2024 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $3,763.69 General
09/06/2024 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $1,500.31 General
07/29/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $800.00 General
06/24/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $325.00 General
05/16/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $2,600.00 General
05/06/2024 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $2,082.50 General
04/17/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $1,225.00 General
02/16/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $650.00 General
01/04/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $975.00 General
12/08/2023 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $5,850.00 General
12/04/2023 PFIZER INC. Consulting Fee Cash or cash equivalent $5,500.00 General
11/22/2023 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $1,950.00 General
11/12/2023 Becton, Dickinson and Company Food and Beverage In-kind items and services $124.19 General
11/01/2023 Ferring Pharmaceuticals Inc. EUFLEXXA (Device) Food and Beverage In-kind items and services $14.54 General
Category: ORTHOPEDICS
10/18/2023 Novo Nordisk Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
10/05/2023 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $8,478.75 General
10/05/2023 Novo Nordisk Inc Travel and Lodging In-kind items and services $432.51 General
10/05/2023 Novo Nordisk Inc Travel and Lodging In-kind items and services $399.20 General
10/05/2023 Novo Nordisk Inc Travel and Lodging In-kind items and services $189.00 General
10/05/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $57.96 General
09/09/2023 Avanos Medical CORTRAK (Device) Food and Beverage In-kind items and services $18.28 General
Category: DIGESTIVE HEALTH
07/11/2023 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $2,975.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 160 206 $98,844 $19,932
2022 5 112 151 $83,869 $18,144
2021 4 77 118 $55,275 $13,480
2020 5 70 112 $54,754 $11,013
Total Patients
419
Total Services
587
Medicare Billing
$62,568
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 22 29 $16,521 $3,997 24.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 52 $14,968 $3,518 23.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 20 28 $15,704 $3,211 20.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 22 23 $19,034 $2,574 13.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 12 12 $9,904 $1,919 19.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 18 $7,602 $1,802 23.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 11 11 $8,535 $1,530 17.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 16 17 $6,021 $1,247 20.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 14 16 $555.00 $134.40 24.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 27 38 $20,326 $4,661 22.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 21 44 $17,624 $3,806 21.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 16 16 $12,979 $2,884 22.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 18 18 $17,835 $2,841 15.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 11 15 $8,365 $2,327 27.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 19 20 $6,740 $1,623 24.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 17 31 $16,099 $3,927 24.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 19 41 $15,839 $3,648 23.0%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 14 14 $10,094 $2,271 22.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 12 14 $7,476 $2,074 27.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 15 18 $5,767 $1,560 27.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 18 47 $17,543 $4,201 23.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 18 24 $12,392 $2,322 18.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 11 12 $10,944 $2,088 19.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 11 11 $8,241 $1,249 15.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 12 18 $5,634 $1,153 20.5%

About Michael Charlton

Michael Charlton is a Transplant Hepatology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821064692.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Charlton has received a total of $360,944 in payments from pharmaceutical and medical device companies, with $44,827 received in 2024. These payments were reported across 220 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($319,516).

As a Medicare-enrolled provider, Charlton has provided services to 419 Medicare beneficiaries, totaling 587 services with total Medicare billing of $62,568. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Transplant Hepatology
  • Location Chicago, IL
  • Active Since 02/23/2006
  • Last Updated 10/24/2022
  • Taxonomy Code 207RT0003X
  • Entity Type Individual
  • NPI Number 1821064692

Products in Payments

  • REZDIFFRA (Drug) $26,106
  • Wako HCC Biomarker(s) DCP and AFP-L3 (Device) $1,985
  • ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization (Device) $434.10
  • ZORTRESS (Drug) $318.82
  • XIFIXAN (Drug) $184.78
  • OCALIVA (Drug) $166.61
  • Cook Medical Endoscopic Ultrasound (Device) $135.03
  • GORE CARDIOFORM Septal Occluder (Device) $53.43
  • EUFLEXXA (Device) $28.24
  • LIVTENCITY (Drug) $22.18
  • Stivarga (Drug) $20.42
  • CORTRAK (Device) $18.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Transplant Hepatology Doctors in Chicago